XML 27 R12.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair Value Measurement of Assets and Liabilities
3 Months Ended
Mar. 31, 2018
Fair Value Disclosures [Abstract]  
Fair Value Measurement of Assets and Liabilities
Fair Value Measurement of Assets and Liabilities

The following tables present our financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2018 and December 31, 2017 (in millions):
 
March 31, 2018
 
Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
Assets:
 
 
 
 
 
Cash and cash equivalents
$
2,527

 
$
2,527

 
$

Short-term investments:
 
 
 
 
 
Restricted cash
19

 
19

 

Corporate debt securities
2,260

 

 
2,260

Total short-term investments
2,279

 
19

 
2,260

Derivatives
31

 

 
31

Long-term investments:
 
 
 
 
 
Corporate debt securities
5,017

 

 
5,017

Total long-term investments
5,017

 

 
5,017

Total financial assets
$
9,854

 
$
2,546

 
$
7,308

 
 
 
 
 
 
Liabilities:
 
 
 
 
 
Derivatives
$
86

 
$

 
$
86


 
December 31, 2017
 
Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
Assets:
 
 
 
 
 
Cash and cash equivalents
$
2,120

 
$
2,120

 
$

Short-term investments:
 
 
 
 
 
Restricted cash
20

 
20

 

Corporate debt securities
3,723

 

 
3,723

Total short-term investments
3,743

 
20

 
3,723

Derivatives
28

 

 
28

Long-term investments:
 
 
 
 
 
Corporate debt securities
5,446

 

 
5,446

Total long-term investments
5,446

 

 
5,446

Total financial assets
$
11,337

 
$
2,140

 
$
9,197

 
 
 
 
 
 
Liabilities:
 
 
 
 
 
Derivatives
$
29

 
$

 
$
29


 
Our financial assets and liabilities are valued using market prices on both active markets (Level 1) and less active markets (Level 2). Level 1 instrument valuations are obtained from real-time quotes for transactions in active exchange markets involving identical assets. Level 2 instrument valuations are obtained from readily available pricing sources for comparable instruments, identical instruments in less active markets, or models using market observable inputs. The majority of our derivative instruments are valued using pricing models that take into account the contract terms as well as multiple inputs where applicable, such as equity prices, interest rate yield curves, option volatility and currency rates. We did not have any transfers of financial instruments between valuation levels during the three months ended March 31, 2018.

Other financial instruments, including accounts receivable and accounts payable, are carried at cost, which approximates their fair value because of the short-term nature of these instruments.